The targeted histone deacetylase inhibitor tefinostat (CHR-2845) shows selective in vitro efficacy in monocytoid-lineage leukaemias
靶向组蛋白去乙酰化酶抑制剂特非司他 (CHR-2845) 在单核细胞系白血病中表现出选择性体外疗效
期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.7692
Joanna Zabkiewicz, Marie Gilmour, Robert Hills, Pares Vyas, Elizabeth Bone, Alan Davidson, Alan Burnett, Steven Knapper
肿瘤
表观遗传
白血病
单核细胞
Cell sorting
FCM
